首页|美罗培南基于TDM个体化治疗重症感染患者的研究应用

美罗培南基于TDM个体化治疗重症感染患者的研究应用

扫码查看
重症感染是患者安全和生存率的重要威胁。美罗培南作为院内感染的主要治疗药物,由于耐药性的出现,治疗效果受到限制,尤其是在长期使用抗生素后常见耐药性。因此,优化美罗培南等抗生素的疗效并避免微生物耐药性成为急需解决的问题。治疗药物监测(TDM)作为实现个体化给药的重要工具,在重症患者和肾功能不全患者中越来越被认为是优化抗生素浓度、避免治疗失败和毒性的重要策略。本文通过综述美罗培南的应用现状、药代动力学和TDM指导,以为危重症患者和肾功能不全患者的治疗提供参考,为优化抗生素治疗提供依据。
Research and application of personalized treatment of severe infec-tion patients with Meropenem based on TDM
Severe infection is a significant threat to patient safety and survival.As the main treat-ment for hospital acquired infections,meropenem is limited in its effectiveness due to the emergence of drug resistance,especially after long-term use of antibiotics.Therefore,optimizing the efficacy of an-tibiotics such as meropenem and avoiding microbi-al resistance has become an urgent issue to be ad-dressed.Therapeutic drug monitoring(TDM),as an important tool for achieving personalized drug ad-ministration,is increasingly recognized as an impor-tant strategy for optimizing antibiotic concentra-tion,avoiding treatment failure and toxicity in criti-cally ill patients and patients with renal insufficien-cy.By reviewing the current application status,pharmacokinetics,and TDM guidance of meropen-em,clinical references are provided for the treat-ment of critically ill patients and patients with renal insufficiency,and guidance and support are provid-ed for optimizing antibiotic treatment.

meropenemTDMsevere infectionrenal dysfunction

王文娟、路佩源、杨晓彤、陈莉、赵银枝、袁媛

展开 >

甘肃中医药大学,第一临床医学院

甘肃省人民医院重症医学科,兰州 730000,甘肃

美罗培南 TDM 重症感染 肾功能异常

2024

中国临床药理学与治疗学
中国药理学会

中国临床药理学与治疗学

CSTPCD北大核心
影响因子:0.97
ISSN:1009-2501
年,卷(期):2024.29(12)